RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Innovative Pharmaceutical Biotech Employees 2024

Innovative Pharmaceutical Biotech Employees

23

Innovative Pharmaceutical Biotech Dividend yield

Ticker

399.HK

ISIN

BMG4783W1073

WKN

A1416X

In 2024, Innovative Pharmaceutical Biotech employed 23 people, a 0% change from the 23 number of employees in the previous year.

Innovative Pharmaceutical Biotech Aktienanalyse

What does Innovative Pharmaceutical Biotech do?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Innovative Pharmaceutical Biotech's Employee Base

Innovative Pharmaceutical Biotech's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Innovative Pharmaceutical Biotech's operational capacity and future potential.

Year-to-Year Comparison

Assessing Innovative Pharmaceutical Biotech's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Innovative Pharmaceutical Biotech's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Innovative Pharmaceutical Biotech’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Innovative Pharmaceutical Biotech Stock

How many employees does Innovative Pharmaceutical Biotech have this year?

Innovative Pharmaceutical Biotech has 23 undefined employees this year.

How many employees did Innovative Pharmaceutical Biotech have compared to the previous year?

Compared to the previous year, Innovative Pharmaceutical Biotech had 0% more employees.

What impact did the number of employees have on the company Innovative Pharmaceutical Biotech?

The number of employees has a direct impact on the efficiency and productivity of Innovative Pharmaceutical Biotech. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Innovative Pharmaceutical Biotech?

The number of employees can also have an impact on investors of Innovative Pharmaceutical Biotech, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Innovative Pharmaceutical Biotech affect the company?

An increase in equity of Innovative Pharmaceutical Biotech can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Innovative Pharmaceutical Biotech's equity affect the company?

A reduction in equity of Innovative Pharmaceutical Biotech can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Innovative Pharmaceutical Biotech?

Some factors that can influence the equity of Innovative Pharmaceutical Biotech include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Innovative Pharmaceutical Biotech so important for investors?

The equity of Innovative Pharmaceutical Biotech is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Innovative Pharmaceutical Biotech influence the company?

The number of employees at Innovative Pharmaceutical Biotech can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Innovative Pharmaceutical Biotech evolved in recent years?

In recent years, the number of employees at Innovative Pharmaceutical Biotech has changed by 0.

How many employees does Innovative Pharmaceutical Biotech currently have?

Innovative Pharmaceutical Biotech currently has 23 undefined employees.

Why is the number of employees important for investors of Innovative Pharmaceutical Biotech?

The number of employees is important for investors of Innovative Pharmaceutical Biotech as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Innovative Pharmaceutical Biotech take to change the number of employees?

To change the number of employees, Innovative Pharmaceutical Biotech can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Innovative Pharmaceutical Biotech pay?

Over the past 12 months, Innovative Pharmaceutical Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovative Pharmaceutical Biotech is expected to pay a dividend of 0 HKD.

What is the dividend yield of Innovative Pharmaceutical Biotech?

The current dividend yield of Innovative Pharmaceutical Biotech is .

When does Innovative Pharmaceutical Biotech pay dividends?

Innovative Pharmaceutical Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovative Pharmaceutical Biotech?

Innovative Pharmaceutical Biotech paid dividends every year for the past 0 years.

What is the dividend of Innovative Pharmaceutical Biotech?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovative Pharmaceutical Biotech located?

Innovative Pharmaceutical Biotech is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovative Pharmaceutical Biotech from 12/31/2003 amounting to 0.02 HKD, you needed to have the stock in your portfolio before the ex-date on 12/10/2003.

When did Innovative Pharmaceutical Biotech pay the last dividend?

The last dividend was paid out on 12/31/2003.

What was the dividend of Innovative Pharmaceutical Biotech in the year 2023?

In the year 2023, Innovative Pharmaceutical Biotech distributed 0 HKD as dividends.

In which currency does Innovative Pharmaceutical Biotech pay out the dividend?

The dividends of Innovative Pharmaceutical Biotech are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovative Pharmaceutical Biotech

Our stock analysis for Innovative Pharmaceutical Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovative Pharmaceutical Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.